NanoViricides Inc. (NNVC)

[BonelessCat]

The disease of the month, Ebola, is not interfering with the start of tox studies. The tox studies will start shortly and just after that the anti-Ebola cide will be produced following a successful computer simulation model as developed by Diwan. As anyone should know who knows the company and has read all the PRs and filings the virus targeting nanomicelle is first constructed as a computer simulation. After successful simulation the specific nanoviricide is constructed and tested in the lab. This simulation is part of the rapid drug development platform.